查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827667

2025年全球體外診斷市場報告

In Vitro Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，體外診斷市場快速擴張，市場規模將從2024年的1,219.6億美元成長至2025年的1,365.5億美元，複合年成長率達12.0%。預測期內的成長主要受自動化分析儀和分子診斷技術的發展、人口老化、疾病爆發、醫療法規以及個人化醫療等因素的推動。

預計未來幾年體外診斷市場將快速成長，到2029年將達到2,148.8億美元，複合年成長率為12.0%。預測期內的成長可歸因於精準醫療、就地檢驗、數位健康和​​數據分析以及疫情預防措施。預測期內的主要趨勢包括技術進步、數位健康整合、個人化診斷、家用檢測套組和分子診斷。

體外診斷 (IVD) 是指對從人體採集的生物樣本（例如血液、組織或尿液）進行的檢測，用於識別疾病、病症和感染疾病。這些檢測在受控環境（例如實驗室）中使用專門的設備和試劑在體外進行。 IVD 在診斷各種健康狀況、確定治療方案以及長期監測患者健康狀況方面發揮著重要作用。

體外診斷的主要類別包括照護現場診斷儀器和設備、免疫化學診斷儀器和設備、臨床化學診斷儀器和設備、分子診斷儀器和設備、微生物學診斷儀器和設備、止血診斷儀器和設備、血液學診斷儀器和設備以及免疫血液學診斷儀器和設備。例如，血液學儀器是用於分析血液樣本、測量血球計數、檢測蛋白質和酵素以及輔助診斷疾病和基因缺陷的機器。這些儀器和設備在公共和私人場所都有使用，不僅包括儀器和設備，還包括耗材。這些設備的最終用戶包括醫院、診所、診斷實驗室和其他相關機構。

2025年春季美國關稅突然上調及其引發的貿易摩擦，對醫療設備領域產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰進一步加劇了形勢，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供了體外診斷醫療器材市場的統計數據，包括全球市場規模、各地區市場佔有率、各競爭對手的市場佔有率、體外診斷醫療器材市場的細分市場、市場趨勢和機遇，以及在體外診斷醫療器材行業取得成功所需的數據。這份體外診斷醫療設備市場研究報告提供了所有必要資訊的完整展望，並對產業現狀和未來情勢進行了詳細分析。

我們對該市場未來五年12.0%的成長率預測與先前的預測保持一致。造成這一下降的主要原因是美國與其他國家之間關稅的影響。這可能會透過對來自台灣和荷蘭等關鍵地區的微流體晶片和高靈敏度生物感測器徵收關稅直接影響美國，從而導致檢測能力下降和臨床實驗室營運成本上升。此外，由於貿易緊張局勢加劇和限制措施加劇，互惠關稅以及對全球經濟和貿易的負面影響也將更廣泛地顯現。

預計未來幾年，自助檢測套組的普及將推動體外診斷市場的擴張。這些檢測套組專為自助使用而設計，無需醫療專業人員或受過培訓的人員進行檢測，人們可以在家中進行診斷評估。這種可近性和便利性的提高可能會增加對檢測的需求，尤其是對那些以前可能未被發現的疾病的檢測需求。例如，美國疾病管制與預防中心 2022 年 4 月的統計數據顯示，在美國18 歲及以上的成年人中，使用家庭 COVID-19 檢測的人數顯著增加。將Delta占主導地位的時期（2021 年 8 月至 12 月）與 Omicron 占主導地位的時期（2022 年 12 月至 3 月）進行比較，在出現 COVID-19 樣症狀的受訪者中，使用家庭檢測的比例顯著增加，從 5.7% 上升到 20.1%。因此，自我管理檢測套組的日益普及預計將推動體外診斷市場的成長。

預計癌症盛行率的上升將推動體外診斷市場的發展。癌症涵蓋多種疾病，在身體各部位有 100 多種表現，其特徵是細胞不受控制地生長和擴散。體外診斷 (IVD) 包括分析從人體採集的樣本的測試和醫療設備，以提供癌症篩檢、診斷和治療所必需的資訊。例如，美國政府間組織國家生物技術資訊中心在 2023 年 1 月預測，2023 年美國新增癌症病例數和癌症相關死亡人數將分別達到 1,958,310 例和 609,820 例。因此，癌症發生率的預期成長將推動體外診斷市場的成長。

體外診斷市場的主要企業正專注於開發創新產品，例如 Cobas 脈搏系統，這是一種專門的血糖管理解決方案，具有行動數位健康功能，可增強患者照護。例如，2022 年 1 月，羅氏診斷公司（Roche Diagnostics）推出了 Cobas 脈搏系統，這是一家專門從事疾病預防、診斷、監測、篩檢和治療創新產品和服務的美國公司。這款攜帶式設備由自動血糖試紙讀取器、相機和用於捕獲其他診斷數據的觸控螢幕組成。使用者友善的介面旨在實現無縫整合，並包含最佳化流程、節省時間和改進操作工作流程的便利功能。

體外診斷 (IVD) 市場的主要企業正在整合先進技術，例如 UIMG 成像技術和2D解碼晶片，以提高診斷準確性和效率，改進數據分析，最佳化工作流程，並最終改善患者預後。 UIMG 成像技術是一種用於診斷的先進成像技術，用於捕捉和分析高解析度影像，從而增強生物樣本的可視化和解讀能力。例如，2023 年 11 月，總部位於荷蘭、服務於歐洲、中東和非洲的科技公司 Neuland 推出了新的 IVD 產品線。該產品線包含五種緊湊耐用的條碼掃描器，旨在最佳化自動化診斷流程，滿足日益成長的高效醫療保健解決方案需求，並提高診斷速度和準確性。

體外診斷市場的主要企業包括西門子醫療公司、羅氏公司、丹納赫集團、雅培實驗室公司、賽默飛世爾科技公司、安捷倫科技公司、美利堅合眾國公司、Arkray公司、碧迪公司、Bio-Rad實驗室公司、bioMerieux SA、Grifols SA、Hologic公司、Werfen。 SA、Laboratory Corporation、Luminex Corporation、Ortho Clinical Diagnostics、PerkinElmer Inc.、Qiagen NV、Quest Diagnostics Inc.、QuidelOrtho Corporation、Sysmex Corporation、Illumina Inc.、Menarini Silicon Biosystems SPA、SpeeDx Pty.Ltd.、GGEEDAV​​Ax 或Ak 或k 或kOR、F錯誤. Sciences Inc.、Bio-Techne Corporation、Myriad Genetics Inc.、Genomic Health Inc.、Exact Sciences Crop.、Natera Inc.、Invitae Crop. 和 Veracyte Inc.

2024年，北美是全球體外診斷市場最大的地區。亞太地區是全球體外診斷市場的第二大地區。體外診斷設備和器械市場報告涵蓋亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

IVD市場報告涵蓋澳洲、中國、印度、印尼、日本、韓國、孟加拉、泰國、越南、馬來西亞、新加坡、菲律賓、香港、紐西蘭、美國、加拿大、墨西哥、巴西、智利、阿根廷、哥倫比亞、秘魯、法國、德國、英國、奧地利、比利時、丹麥、芬蘭、愛爾蘭、義大利、荷蘭、英國、葡萄牙、西班牙、瑞典、瑞士、俄羅斯、捷克共和國、波蘭聯合國、美國、歐洲、伊朗、伊朗、俄羅斯、伊朗、俄羅斯、俄羅斯和伊朗、民族、伊朗、伊朗、埃及、伊朗、俄羅斯和伊朗、伊朗、俄羅斯和伊朗、伊朗、伊朗、俄羅斯和伊朗、伊朗、伊朗、俄羅斯和伊朗、民族、伊朗、歐洲、伊朗、伊朗、俄羅斯、伊朗、伊朗、俄羅斯和伊朗、民族、伊朗、歐洲、伊朗、伊朗、俄羅斯、伊朗、伊朗、歐洲、伊朗、伊朗、民族、伊朗、歐洲、伊朗、伊朗、伊朗、伊朗、伊朗、俄羅斯、歐洲、伊朗、歐洲、伊朗、伊朗、歐洲、伊朗、歐洲、伊朗、」伊朗、歐洲、美國、伊朗、歐洲、伊朗、伊朗、歐洲、伊朗、伊朗、俄羅斯、美國、伊朗、歐洲、美國、伊朗、歐洲、伊朗、」

體外診斷市場包括套件、試劑、軟體、系統和儀器的銷售。該市場的價值是指“出廠價”，即商品製造商或創造者銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的價值。該市場中的商品價值還包括商品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球體外診斷：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球體外診斷市場：成長率分析
  • 全球體外診斷市場表現：規模與成長，2019-2024
  • 全球體外診斷市場預測：規模與成長，2024-2029年，2034年
  • 全球體外診斷：總目標市場（TAM）

第6章 市場細分

  • 全球體外診斷市場類型、績效及預測（2019-2024、2024-2029、2034）
  • 照護現場診斷設備和儀器
  • 免疫化學診斷儀器設備
  • 臨床化學診斷設備與儀器
  • 分子診斷設備與儀器
  • 微生物診斷設備與儀器
  • 血液凝固診斷儀器及設備
  • 血液診斷設備
  • 免疫血液學診斷設備及儀器
  • 全球體外診斷市場支出類型、實際及預測（2019-2024、2024-2029、2034）
  • 公共
  • 私人的
  • 全球體外診斷市場用途、表現及預測（2019-2024、2024-2029、2034）
  • 用具/設備
  • 一次性的
  • 全球體外診斷市場最終用戶、績效及預測（2019-2024、2024-2029、2034）
  • 醫院和診所
  • 診斷實驗室
  • 其他
  • 全球體外診斷市場：照護現場診斷設備和儀器細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 血糖監測
  • 妊娠和生育能力測試
  • 傳染病檢查
  • 心臟標記檢測
  • 血液凝固檢驗
  • 全球體外診斷市場：免疫化學診斷儀器和設備細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 酵素免疫分析法（ELISA）
  • 免疫檢測（RIA）
  • 蛋白質印跡法
  • 螢光試驗
  • 化學冷光免疫檢測（CLIA）
  • 全球體外診斷市場：臨床化學診斷儀器和設備細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 血糖值檢測
  • 膽固醇檢測
  • 肝功能檢查
  • 腎功能檢查
  • 電解質測試
  • 全球體外診斷市場：分子診斷設備和儀器細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • PCR（聚合酵素鏈鎖反應）設備
  • 下一代定序（NGS）設備
  • 微陣列設備
  • FISH（螢光原位雜合反應）設備
  • 全球體外診斷市場：微生物診斷儀器和設備細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 微生物培養系統
  • 自動辨識系統
  • 抗菌藥物敏感性測試系統
  • 血液培養系統
  • 全球體外診斷市場：止血診斷儀器和設備細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 凝血分析儀
  • 血栓彈力圖系統
  • 血小板功能分析儀
  • 凝血因子分析儀
  • 全球體外診斷市場：血液學診斷儀器和設備細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 血液分析儀
  • 血紅素檢測系統
  • 全血細胞計數（CBC）儀
  • 血球計數器
  • 全球體外診斷市場：免疫血液學診斷器材與設備細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 血型系統
  • 交叉配對檢查系統
  • 抗體篩檢系統
  • 血庫分析儀

第7章 區域和國家分析

  • 全球體外診斷市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球體外診斷市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 孟加拉市場

第16章 泰國市場

第17章 越南市場

第18章 馬來西亞市場

第19章：新加坡市場

第20章：菲律賓市場

第21章 香港市場

第22章：紐西蘭市場

第23章 西歐市場

第24章英國市場

第25章：德國市場

第26章：法國市場

第27章：義大利市場

第28章：西班牙市場

第29章：西班牙市場

第30章：奧地利市場

第31章：比利時市場

第32章：丹麥市場

第33章 芬蘭市場

第34章：愛爾蘭市場

第35章：荷蘭市場

第36章：挪威市場

第37章：葡萄牙市場

第38章：瑞典市場

第39章：瑞士市場

第41章俄羅斯市場

第42章 捷克共和國市場

第43章：波蘭市場

第44章：羅馬尼亞市場

第45章：烏克蘭市場

第46章 北美市場

第47章美國市場

第48章：加拿大市場

第50章：南美市場

第51章：巴西市場

第52章 智利市場

第53章：阿根廷市場

第54章：哥倫比亞市場

第55章秘魯市場

第56章 中東市場

第57章：沙烏地阿拉伯市場

第58章：以色列市場

第59章 伊朗市場

第60章 土耳其市場

第61章：阿拉伯聯合大公國市場

第62章 非洲市場

第63章埃及市場

第64章 奈及利亞市場

第65章南非市場

第66章：競爭格局與公司概況

  • 體外診斷市場：競爭格局
  • 體外診斷市場：公司簡介
    • Siemens Healthineers
    • F. Hoffmann-La Roche AG
    • Danaher Corporation
    • Abbott Laboratories Inc.
    • Thermo Fisher Scientific Inc.

第 67 章：其他領先和創新企業

  • Agilent Technologies Inc.
  • Alere Inc.
  • Arkray Inc.
  • Becton, Dickinson and Company（BD）
  • Bio-Rad Laboratories Inc.
  • bioMerieux SA
  • Grifols SA
  • Hologic Inc.
  • Werfen SA
  • Laboratory Corporation
  • Luminex Corporation
  • Ortho Clinical Diagnostics
  • PerkinElmer Inc.
  • Qiagen NV
  • Quest Diagnostics Inc.

第 68 章：全球市場競爭基準化分析與儀錶板

第69章：重大併購

第70章近期市場趨勢

第71章：市場潛力大的國家與策略

  • 2029年體外診斷市場：提供新機會的國家
  • 2029年體外診斷市場：細分領域帶來新機會
  • 2029年體外診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第72章 附錄

簡介目錄
Product Code: r32599u

In vitro diagnostics (IVD) are tests performed on biological samples, such as blood, tissue, or urine, collected from the human body to identify diseases, conditions, or infections. Conducted outside the body in controlled environments like laboratories, these tests utilize specialized equipment and reagents. IVDs play a vital role in diagnosing various health conditions, guiding treatment decisions, and monitoring patient health over time.

The principal categories of in-vitro diagnostics equipment encompass point-of-care diagnostics devices and equipment, immunochemistry diagnostic devices and equipment, clinical chemistry diagnostics devices and equipment, molecular diagnostics devices and equipment, microbiology diagnostic devices and equipment, hemostasis diagnostic devices and equipment, hematology diagnostic devices and equipment, and immunohematology diagnostic devices and equipment. Hematology instruments, for instance, are machines designed to analyze blood samples, perform blood counts, detect proteins or enzymes, and aid in the diagnosis of diseases or genetic defects. These devices and equipment are used in both public and private settings and involve instruments/equipment as well as disposables. The end-users for these tools include hospitals and clinics, diagnostic laboratories, and other relevant institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The in-vitro diagnostics devices and equipment market research report is one of a series of new reports from The Business Research Company that provides in-vitro diagnostics devices and equipment market statistics, including in-vitro diagnostics devices and equipment industry global market size, regional shares, competitors with an in-vitro diagnostics devices and equipment market share, detailed in-vitro diagnostics devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the in-vitro diagnostics devices and equipment industry. This in-vitro diagnostics devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in vitro diagnostics market size has grown rapidly in recent years. It will grow from $121.96 billion in 2024 to $136.55 billion in 2025 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to the development of automated analyzers and molecular diagnostics, aging population, disease outbreaks, healthcare regulations, personalized medicine.

The in vitro diagnostics market size is expected to see rapid growth in the next few years. It will grow to $214.88 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to precision medicine, point-of-care testing, digital health and data analytics, pandemic preparedness. Major trends in the forecast period include technological advancements, digital health integration, personalized diagnostics, home testing kits, molecular diagnostics.

The forecast of 12.0% growth over the next five years remains unchanged from the previous projection for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on microfluidic chips and high-sensitivity biosensors, sourced from key regions such as Taiwan and the Netherlands, which could lead to reduced testing capacity and increased costs for clinical laboratory operations.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing adoption of self-administered test kits is set to fuel the expansion of the in vitro diagnostics market in the forthcoming years. These kits are designed for self-use, eliminating the necessity for medical professionals or trained individuals to conduct the tests, allowing people to perform diagnostic evaluations at their residences. This increased accessibility and convenience could potentially result in a higher demand for testing, especially for conditions that may have previously gone undetected. For example, statistics from the Centers for Disease Control and Prevention in April 2022 exhibited a significant surge in the use of at-home COVID-19 tests among adults aged 18 and older in the United States. Comparing the Delta-dominant period (August to December 2021) to the Omicron-dominant period (December to March 2022), there was a notable increase in at-home test utilization among respondents experiencing symptoms resembling COVID-19, rising from 5.7% to 20.1%. Hence, the increasing adoption of self-administered test kits is anticipated to be a driving factor in the growth of the in vitro diagnostics market.

The projected rise in the prevalence of cancer is expected to drive the expansion of the in vitro diagnostics market. Cancer comprises a wide array of over 100 diseases that can manifest in various parts of the body, characterized by the uncontrolled proliferation and dissemination of cells. In vitro diagnostics (IVDs) encompass tests or medical devices that analyze samples obtained from the human body, providing vital information for the screening, diagnosis, and treatment of cancer. For instance, in January 2023, the National Center for Biotechnology Information, a US-based intergovernmental organization, projected that there would be 1,958,310 new cancer cases and 609,820 cancer-related deaths in the United States for the year 2023. Consequently, the anticipated rise in cancer prevalence is set to drive the growth of the in vitro diagnostics market.

Key companies in the in vitro diagnostics market are focusing on the development of innovative products to drive their market growth, such as the Cobas pulse system. This system is a professional blood glucose management solution equipped with mobile digital health capabilities to enhance patient care. For example, in January 2022, Roche Diagnostics, a US-based company specializing in innovative products and services addressing disease prevention, diagnosis, monitoring, screening, and treatment, introduced the Cobas pulse system. This portable device comprises an automated glucose test strip reader, a camera, and a touchscreen for capturing additional diagnostic data. Its user-friendly interface is designed for seamless integration, providing convenient functionalities that optimize processes, save time, and improve operational workflows.

Major players in the in vitro diagnostics (IVD) market are incorporating advanced technologies, such as UIMG image technology and 2D decoder chips, to enhance diagnostic accuracy and efficiency, improve data analysis, optimize workflows, and ultimately deliver better patient outcomes. UIMG image technology is an advanced imaging technique used in diagnostics to capture and analyze high-resolution images, enhancing the visualization and interpretation of biological samples. For example, in November 2023, Newland, a Netherlands-based technology company in the EMEA region, launched a new IVD product line. This product line includes five barcode scanners that are compact, durable, and designed to optimize automated diagnostic processes, aiming to boost diagnostic speed and accuracy in response to the growing demand for efficient healthcare solutions.

Major companies operating in the in vitro diagnostics market include Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMerieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.

North America was the largest region in the global in-vitro diagnostics market in 2024. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in-vitro diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the in vitro diagnostics market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa

The in-vitro diagnostics devices and equipment market consist of sales of kits, reagents, piece of software, system, and instrument. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Vitro Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in vitro diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in vitro diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in vitro diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Point-of-Care Diagnostics Devices And Equipment; Immunochemistry Diagnostic Devices And Equipment; Clinical Chemistry Diagnostics Devices And Equipment; Molecular Diagnostics Devices And Equipment; Microbiology Diagnostic Devices And Equipment; Hemostasis Diagnostic Devices And Equipment; Hematology Diagnostic Devices And Equipment; Immunohematology Diagnostic Devices And Equipment
  • 2) By End User: Hospitals And Clinics; Diagnostic Laboratories; Other End Users
  • 3) By Type of Expenditure: Public; Private
  • 4) By Product: Instruments/Equipment; Disposables
  • Subsegments:
  • 1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring; Pregnancy And Fertility Testing; Infectious Disease Testing; Cardiac Markers Testing; Coagulation Testing
  • 2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA); Radioimmunoassay (RIA); Western Blot; Immunofluorescence Assay; Chemiluminescence Immunoassay (CLIA)
  • 3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing; Cholesterol Testing; Liver Function Testing; Kidney Function Testing; Electrolyte Testing
  • 4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments; Next-Generation Sequencing (NGS) Instruments; Microarray Instruments; FISH (Fluorescence In Situ Hybridization) Devices
  • 5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems; Automated Identification Systems; Antimicrobial Susceptibility Testing Systems; Blood Culture Systems
  • 6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers; Thromboelastography Systems; Platelet Function Analyzers; Clotting Factor Analyzers
  • 7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers; Hemoglobin Testing Systems; Complete Blood Count (CBC) Devices; Blood Cell Counters
  • 8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems; Crossmatching Systems; Antibody Screening Systems; Blood Bank Analyzers
  • Companies Mentioned: Siemens Healthineers; F. Hoffmann-La Roche AG; Danaher Corporation; Abbott Laboratories Inc.; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; Alere Inc.; Arkray Inc.; Becton, Dickinson and Company (BD); Bio-Rad Laboratories Inc.; bioMerieux SA; Grifols SA; Hologic Inc.; Werfen SA; Laboratory Corporation; Luminex Corporation; Ortho Clinical Diagnostics; PerkinElmer Inc.; Qiagen NV; Quest Diagnostics Inc.; QuidelOrtho Corporation; Sysmex Corporation; Illumina Inc.; Menarini Silicon Biosystems SPA; SpeeDx Pty. Ltd.; GENSPEED Biotech GmbH; Accelerate Diagnostics Inc.; Merck KGaA; Caris Life Sciences Inc.; Bio-Techne Corporation; Myriad Genetics Inc.; Genomic Health Inc.; Exact Sciences Crop.; Natera Inc.; Invitae Crop.; Veracyte Inc.
  • Countries: Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In Vitro Diagnostics Market Characteristics

3. In Vitro Diagnostics Market Trends And Strategies

4. In Vitro Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global In Vitro Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global In Vitro Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global In Vitro Diagnostics Market Growth Rate Analysis
  • 5.4. Global In Vitro Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global In Vitro Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global In Vitro Diagnostics Total Addressable Market (TAM)

6. In Vitro Diagnostics Market Segmentation

  • 6.1. Global In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Point-of-Care Diagnostics Devices And Equipment
  • Immunochemistry Diagnostic Devices And Equipment
  • Clinical Chemistry Diagnostics Devices And Equipment
  • Molecular Diagnostics Devices And Equipment
  • Microbiology Diagnostic Devices And Equipment
  • Hemostasis Diagnostic Devices And Equipment
  • Hematology Diagnostic Devices And Equipment
  • Immunohematology Diagnostic Devices And Equipment
  • 6.2. Global In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Public
  • Private
  • 6.3. Global In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments/Equipment
  • Disposables
  • 6.4. Global In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Other End Users
  • 6.5. Global In Vitro Diagnostics Market, Sub-Segmentation Of Point-of-Care Diagnostics Devices and Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Glucose Monitoring
  • Pregnancy And Fertility Testing
  • Infectious Disease Testing
  • Cardiac Markers Testing
  • Coagulation Testing
  • 6.6. Global In Vitro Diagnostics Market, Sub-Segmentation Of Immunochemistry Diagnostic Devices and Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Radioimmunoassay (RIA)
  • Western Blot
  • Immunofluorescence Assay
  • Chemiluminescence Immunoassay (CLIA)
  • 6.7. Global In Vitro Diagnostics Market, Sub-Segmentation Of Clinical Chemistry Diagnostic Devices and Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Glucose Testing
  • Cholesterol Testing
  • Liver Function Testing
  • Kidney Function Testing
  • Electrolyte Testing
  • 6.8. Global In Vitro Diagnostics Market, Sub-Segmentation Of Molecular Diagnostics Devices and Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PCR (Polymerase Chain Reaction) Instruments
  • Next-Generation Sequencing (NGS) Instruments
  • Microarray Instruments
  • FISH (Fluorescence In Situ Hybridization) Devices
  • 6.9. Global In Vitro Diagnostics Market, Sub-Segmentation Of Microbiology Diagnostic Devices and Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microbial Culture Systems
  • Automated Identification Systems
  • Antimicrobial Susceptibility Testing Systems
  • Blood Culture Systems
  • 6.10. Global In Vitro Diagnostics Market, Sub-Segmentation Of Hemostasis Diagnostic Devices and Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Coagulation Analyzers
  • Thromboelastography Systems
  • Platelet Function Analyzers
  • Clotting Factor Analyzers
  • 6.11. Global In Vitro Diagnostics Market, Sub-Segmentation Of Hematology Diagnostic Devices and Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hematology Analyzers
  • Hemoglobin Testing Systems
  • Complete Blood Count (CBC) Devices
  • Blood Cell Counters
  • 6.12. Global In Vitro Diagnostics Market, Sub-Segmentation Of Immunohematology Diagnostic Devices and Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Typing Systems
  • Crossmatching Systems
  • Antibody Screening Systems
  • Blood Bank Analyzers

7. In Vitro Diagnostics Market Regional And Country Analysis

  • 7.1. Global In Vitro Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global In Vitro Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific In Vitro Diagnostics Market

  • 8.1. Asia-Pacific In Vitro Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China In Vitro Diagnostics Market

  • 9.1. China In Vitro Diagnostics Market Overview
  • 9.2. China In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India In Vitro Diagnostics Market

  • 10.1. India In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan In Vitro Diagnostics Market

  • 11.1. Japan In Vitro Diagnostics Market Overview
  • 11.2. Japan In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia In Vitro Diagnostics Market

  • 12.1. Australia In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia In Vitro Diagnostics Market

  • 13.1. Indonesia In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea In Vitro Diagnostics Market

  • 14.1. South Korea In Vitro Diagnostics Market Overview
  • 14.2. South Korea In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Bangladesh In Vitro Diagnostics Market

  • 15.1. Bangladesh In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.2. Bangladesh In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Bangladesh In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. Thailand In Vitro Diagnostics Market

  • 16.1. Thailand In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. Thailand In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. Thailand In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Vietnam In Vitro Diagnostics Market

  • 17.1. Vietnam In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Vietnam In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Vietnam In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. Malaysia In Vitro Diagnostics Market

  • 18.1. Malaysia In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. Malaysia In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. Malaysia In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Singapore In Vitro Diagnostics Market

  • 19.1. Singapore In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Singapore In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Singapore In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Philippines In Vitro Diagnostics Market

  • 20.1. Philippines In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Philippines In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Philippines In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Hong Kong In Vitro Diagnostics Market

  • 21.1. Hong Kong In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.2. Hong Kong In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Hong Kong In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. New Zealand In Vitro Diagnostics Market

  • 22.1. New Zealand In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. New Zealand In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. New Zealand In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. Western Europe In Vitro Diagnostics Market

  • 23.1. Western Europe In Vitro Diagnostics Market Overview
  • 23.2. Western Europe In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. Western Europe In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. Western Europe In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. UK In Vitro Diagnostics Market

  • 24.1. UK In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.2. UK In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. UK In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Germany In Vitro Diagnostics Market

  • 25.1. Germany In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.2. Germany In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Germany In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. France In Vitro Diagnostics Market

  • 26.1. France In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.2. France In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. France In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Italy In Vitro Diagnostics Market

  • 27.1. Italy In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Italy In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Italy In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Spain In Vitro Diagnostics Market

  • 28.1. Spain In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.2. Spain In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Spain In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Spain In Vitro Diagnostics Market

  • 29.1. Spain In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.2. Spain In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Spain In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Austria In Vitro Diagnostics Market

  • 30.1. Austria In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 30.2. Austria In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 30.3. Austria In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

31. Belgium In Vitro Diagnostics Market

  • 31.1. Belgium In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 31.2. Belgium In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 31.3. Belgium In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

32. Denmark In Vitro Diagnostics Market

  • 32.1. Denmark In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 32.2. Denmark In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 32.3. Denmark In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

33. Finland In Vitro Diagnostics Market

  • 33.1. Finland In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 33.2. Finland In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 33.3. Finland In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

34. Ireland In Vitro Diagnostics Market

  • 34.1. Ireland In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 34.2. Ireland In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 34.3. Ireland In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

35. Netherlands In Vitro Diagnostics Market

  • 35.1. Netherlands In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 35.2. Netherlands In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 35.3. Netherlands In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

36. Norway In Vitro Diagnostics Market

  • 36.1. Norway In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 36.2. Norway In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 36.3. Norway In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

37. Portugal In Vitro Diagnostics Market

  • 37.1. Portugal In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 37.2. Portugal In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 37.3. Portugal In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

38. Sweden In Vitro Diagnostics Market

  • 38.1. Sweden In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 38.2. Sweden In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 38.3. Sweden In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

39. Switzerland In Vitro Diagnostics Market

  • 39.1. Switzerland In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 39.2. Switzerland In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 39.3. Switzerland In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion40. Eastern Europe In Vitro Diagnostics Market
  • 40.1. Eastern Europe In Vitro Diagnostics Market Overview
  • 40.2. Eastern Europe In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 40.3. Eastern Europe In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 40.4. Eastern Europe In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

41. Russia In Vitro Diagnostics Market

  • 41.1. Russia In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 41.2. Russia In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 41.3. Russia In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

42. Czech Republic In Vitro Diagnostics Market

  • 42.1. Czech Republic In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 42.2. Czech Republic In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 42.3. Czech Republic In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

43. Poland In Vitro Diagnostics Market

  • 43.1. Poland In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 43.2. Poland In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 43.3. Poland In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

44. Romania In Vitro Diagnostics Market

  • 44.1. Romania In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 44.2. Romania In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 44.3. Romania In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

45. Ukraine In Vitro Diagnostics Market

  • 45.1. Ukraine In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 45.2. Ukraine In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 45.3. Ukraine In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

46. North America In Vitro Diagnostics Market

  • 46.1. North America In Vitro Diagnostics Market Overview
  • 46.2. North America In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 46.3. North America In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 46.4. North America In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

47. USA In Vitro Diagnostics Market

  • 47.1. USA In Vitro Diagnostics Market Overview
  • 47.2. USA In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 47.3. USA In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 47.4. USA In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

48. Canada In Vitro Diagnostics Market

  • 48.1. Canada In Vitro Diagnostics Market Overview
  • 48.2. Canada In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 48.3. Canada In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 48.4. Canada In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 49.1. Mexico In Vitro Diagnostics Market Overview
  • 49.2. Mexico In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 49.3. Mexico In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 49.4. Mexico In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

50. South America In Vitro Diagnostics Market

  • 50.1. South America In Vitro Diagnostics Market Overview
  • 50.2. South America In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 50.3. South America In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 50.4. South America In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

51. Brazil In Vitro Diagnostics Market

  • 51.1. Brazil In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 51.2. Brazil In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 51.3. Brazil In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

52. Chile In Vitro Diagnostics Market

  • 52.1. Chile In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 52.2. Chile In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 52.3. Chile In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

53. Argentina In Vitro Diagnostics Market

  • 53.1. Argentina In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 53.2. Argentina In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 53.3. Argentina In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

54. Colombia In Vitro Diagnostics Market

  • 54.1. Colombia In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 54.2. Colombia In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 54.3. Colombia In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

55. Peru In Vitro Diagnostics Market

  • 55.1. Peru In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 55.2. Peru In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 55.3. Peru In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

56. Middle East In Vitro Diagnostics Market

  • 56.1. Middle East In Vitro Diagnostics Market Overview
  • 56.2. Middle East In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 56.3. Middle East In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 56.4. Middle East In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

57. Saudi Arabia In Vitro Diagnostics Market

  • 57.1. Saudi Arabia In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 57.2. Saudi Arabia In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 57.3. Saudi Arabia In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

58. Israel In Vitro Diagnostics Market

  • 58.1. Israel In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 58.2. Israel In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 58.3. Israel In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

59. Iran In Vitro Diagnostics Market

  • 59.1. Iran In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 59.2. Iran In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 59.3. Iran In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

60. Turkey In Vitro Diagnostics Market

  • 60.1. Turkey In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 60.2. Turkey In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 60.3. Turkey In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

61. United Arab Emirates In Vitro Diagnostics Market

  • 61.1. United Arab Emirates In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 61.2. United Arab Emirates In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 61.3. United Arab Emirates In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

62. Africa In Vitro Diagnostics Market

  • 62.1. Africa In Vitro Diagnostics Market Overview
  • 62.2. Africa In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 62.3. Africa In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 62.4. Africa In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

63. Egypt In Vitro Diagnostics Market

  • 63.1. Egypt In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 63.2. Egypt In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 63.3. Egypt In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

64. Nigeria In Vitro Diagnostics Market

  • 64.1. Nigeria In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 64.2. Nigeria In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 64.3. Nigeria In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

65. South Africa In Vitro Diagnostics Market

  • 65.1. South Africa In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 65.2. South Africa In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 65.3. South Africa In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

66. In Vitro Diagnostics Market Competitive Landscape And Company Profiles

  • 66.1. In Vitro Diagnostics Market Competitive Landscape
  • 66.2. In Vitro Diagnostics Market Company Profiles
    • 66.2.1. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • 66.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 66.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 66.2.4. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 66.2.5. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

67. In Vitro Diagnostics Market Other Major And Innovative Companies

  • 67.1. Agilent Technologies Inc.
  • 67.2. Alere Inc.
  • 67.3. Arkray Inc.
  • 67.4. Becton, Dickinson and Company (BD)
  • 67.5. Bio-Rad Laboratories Inc.
  • 67.6. bioMerieux SA
  • 67.7. Grifols SA
  • 67.8. Hologic Inc.
  • 67.9. Werfen SA
  • 67.10. Laboratory Corporation
  • 67.11. Luminex Corporation
  • 67.12. Ortho Clinical Diagnostics
  • 67.13. PerkinElmer Inc.
  • 67.14. Qiagen NV
  • 67.15. Quest Diagnostics Inc.

68. Global In Vitro Diagnostics Market Competitive Benchmarking And Dashboard

69. Key Mergers And Acquisitions In The In Vitro Diagnostics Market

70. Recent Developments In The In Vitro Diagnostics Market

71. In Vitro Diagnostics Market High Potential Countries, Segments and Strategies

  • 71.1 In Vitro Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 71.2 In Vitro Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 71.3 In Vitro Diagnostics Market In 2029 - Growth Strategies
    • 71.3.1 Market Trend Based Strategies
    • 71.3.2 Competitor Strategies

72. Appendix

  • 72.1. Abbreviations
  • 72.2. Currencies
  • 72.3. Historic And Forecast Inflation Rates
  • 72.4. Research Inquiries
  • 72.5. The Business Research Company
  • 72.6. Copyright And Disclaimer